Diabetes, prediabetes tied to accelerated brain aging
By
Haymarket Media
Sep 10, 2024
The association was strongest among men and people with poor cardiometabolic health.
Empagliflozin confers kidney-protective benefits after acute MI
By
Haymarket Media
Sep 09, 2024
A reduced risk was seen for total hospitalizations for heart failure, total adverse events of heart failure or all-cause mortality.
6.7 percent of US adults cannot use automatic BP devices due to arm size
By
Haymarket Media
Sep 06, 2024
The findings, with patients whose arm circumference was not in range, were seen for 10 most popular over-the-counter devices sold on Amazon.
Adjunctive IV argatroban, eptifibatide do not cut disability after stroke
By
Haymarket Media
Sep 06, 2024
The findings were seen among patients with acute ischemic stroke who were treated with intravenous thrombolysis within three hours after symptom onset.
Psychological resilience protects against earlier death in older adults
By
Haymarket Media
Sep 05, 2024
The findings were seen when adjusting for demographics, clinical factors and health-related behaviors.
Readmission varies with discharge setting for adult sepsis survivors
By
Haymarket Media
Sep 05, 2024
A high risk for 30-day readmission was seen with discharge to skilled nursing facilities, home health care and home.
Asthma inhalers tied to large greenhouse gas emissions production
By
Haymarket Media
Sep 04, 2024
Metered-dose inhalers were responsible for almost all inhaler-related emissions.
SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Recreational drug use tied to repeat cardiovascular events
By
Haymarket Media
Sep 03, 2024
The mean age of study participants was 63. The findings were seen for repeat events within one year of discharge from the intensive cardiac care unit.
Demographic factors tied to differences in long COVID symptoms
By
Haymarket Media
Aug 30, 2024
Higher symptom intensity was seen among older people, women and non-white individuals.